Loading…

The Straumann Group acquired a 30% stake in its biomaterials partner botiss medical AG for an undisclosed sum, to expand distribution of botiss products and secure access to its technology.
“The Straumann Group has acquired a 30% stake in its biomaterials partner botiss medical AG for an undisclosed sum”botiss.com
Summarized from public sources; check the original articles before acting on it.